{"id":232874,"date":"2026-03-09T19:06:21","date_gmt":"2026-03-10T00:06:21","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/03\/stem-cell-treatments-for-parkinsons-and-heart-failure-approved-in-world-first"},"modified":"2026-03-09T19:06:21","modified_gmt":"2026-03-10T00:06:21","slug":"stem-cell-treatments-for-parkinsons-and-heart-failure-approved-in-world-first","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/03\/stem-cell-treatments-for-parkinsons-and-heart-failure-approved-in-world-first","title":{"rendered":"Stem Cell Treatments For Parkinson\u2019s And Heart Failure Approved in World First"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/stem-cell-treatments-for-parkinsons-and-heart-failure-approved-in-world-first.jpg\"><\/a><\/p>\n<p>Japan has approved ground-breaking <a href=\"https:\/\/www.sciencealert.com\/chinese-trials-to-treat-parkinson-s-disease-and-blindness-with-embryonic-stem-cells\">stem-cell treatments<\/a> for <a href=\"https:\/\/www.sciencealert.com\/go\/IYl\" rel=\"nofollow\" target=\"_self\">Parkinson\u2019s<\/a> and severe heart failure, one of the manufacturers and media reports said Friday, with the therapies expected to reach patients within months.<\/p>\n<p>Pharmaceutical company Sumitomo Pharma <a href=\"https:\/\/www.sumitomo-pharma.com\/news\/20260306.html\">said it received<\/a> the green light for the manufacture and sale of Amchepry, its Parkinson\u2019s disease treatment that transplants <a href=\"https:\/\/www.sciencealert.com\/stem-cells\" rel=\"nofollow\" target=\"_self\">stem cells<\/a> into a patient\u2019s brain.<\/p>\n<p>Japan\u2019s health ministry also gave the go-ahead to ReHeart, heart muscle sheets developed by medical startup Cuorips that can help form new blood vessels and restore heart function, <a href=\"https:\/\/cuorips.co.jp\/en\/news\/2026\/03\/06\/512\/\">media reports said<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Japan has approved ground-breaking stem-cell treatments for Parkinson\u2019s and severe heart failure, one of the manufacturers and media reports said Friday, with the therapies expected to reach patients within months. Pharmaceutical company Sumitomo Pharma said it received the green light for the manufacture and sale of Amchepry, its Parkinson\u2019s disease treatment that transplants stem cells [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495,47],"tags":[],"class_list":["post-232874","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/232874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=232874"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/232874\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=232874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=232874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=232874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}